STOK

SEC source: 0001209191-21-002246 · doc4.xml · nonDerivative · entry 5

Nash Huw M. · CIK 0001780085 · COO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32

F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.50 to $60.515 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-21-002246 · doc4.xml · nonDerivative · entry 4

Nash Huw M. · CIK 0001780085 · COO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 232

F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.395 to $60.33 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-21-002246 · doc4.xml · nonDerivative · entry 3

Nash Huw M. · CIK 0001780085 · COO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,032

F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.395 to $59.355 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-21-002246 · doc4.xml · nonDerivative · entry 2

Nash Huw M. · CIK 0001780085 · COO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,232

F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.33 to $58.13 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-21-002246 · doc4.xml · nonDerivative · entry 1

Nash Huw M. · CIK 0001780085 · COO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,732

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 32 shares of Common Stock acquired under the issuer's employee stock purchase plan on December 31, 2020.

SEC source: 0001209191-21-000508 · doc4.xml · derivative · entry 2

Kaye Edward M. MD · CIK 0001522780 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 637,801

Underlying: Common Stock · 10,000 shares

Expires 2028-04-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option vested as to 1/4th of the total shares on October 17, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date.

SEC source: 0001209191-21-000508 · doc4.xml · nonDerivative · entry 1

Kaye Edward M. MD · CIK 0001522780 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-017869 · doc4.xml · derivative · entry 6

Liau Gene · CIK 0001780082 · EVP Research & Preclinical Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,069

Underlying: Common Stock · 8,000 shares

Expires 2028-04-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vested as to 1/4th of the total shares on January 16, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date.

SEC source: 0001209191-21-017869 · doc4.xml · nonDerivative · entry 2

Liau Gene · CIK 0001780082 · EVP Research & Preclinical Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,351

SEC source: 0001209191-21-017869 · doc4.xml · nonDerivative · entry 1

Liau Gene · CIK 0001780082 · EVP Research & Preclinical Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-064663 · doc4.xml · derivative · entry 5

Ticho Barry · CIK 0001780088 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,400

Underlying: Common Stock · 1,365 shares

Expires 2028-12-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option vested as to 1/48th of the total shares on November 22, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date.

SEC source: 0001209191-20-064663 · doc4.xml · nonDerivative · entry 4

Ticho Barry · CIK 0001780088 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 173,402

F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.86 to $59.05 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-20-064663 · doc4.xml · nonDerivative · entry 3

Ticho Barry · CIK 0001780088 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 173,767

F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.74 to $58.395 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-20-064663 · doc4.xml · nonDerivative · entry 2

Ticho Barry · CIK 0001780088 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174,053

F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.66 to $57.37 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-20-064663 · doc4.xml · nonDerivative · entry 1

Ticho Barry · CIK 0001780088 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174,767

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 740 shares of Common Stock acquired under the issuer's employee stock purchase plan on June 30, 2020.

SEC source: 0001209191-20-064582 · doc4.xml · derivative · entry 6

Nash Huw M. · CIK 0001780085 · COO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 172,371

Underlying: Common Stock · 8,015 shares

Expires 2028-04-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 1/48th of the total shares on February 28, 2018, and then 1/48th of the total shares vest at the end of each month thereafter, subject to the reporting person's continued service to the issuer through each vesting date.

SEC source: 0001209191-20-064582 · doc4.xml · nonDerivative · entry 4

Nash Huw M. · CIK 0001780085 · COO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-20-064582 · doc4.xml · nonDerivative · entry 3

Nash Huw M. · CIK 0001780085 · COO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,015

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-064581 · doc4.xml · nonDerivative · entry 2

Kaye Edward M. MD · CIK 0001522780 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-20-064582 · doc4.xml · derivative · entry 5

Nash Huw M. · CIK 0001780085 · COO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,386

Underlying: Common Stock · 41,985 shares

Expires 2028-04-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 1/48th of the total shares on February 28, 2018, and then 1/48th of the total shares vest at the end of each month thereafter, subject to the reporting person's continued service to the issuer through each vesting date.

SEC source: 0001209191-20-064582 · doc4.xml · nonDerivative · entry 2

Nash Huw M. · CIK 0001780085 · COO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-20-064582 · doc4.xml · nonDerivative · entry 1

Nash Huw M. · CIK 0001780085 · COO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,985

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-064581 · doc4.xml · nonDerivative · entry 1

Kaye Edward M. MD · CIK 0001522780 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,194

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-20-061591 · doc4.xml · derivative · entry 6

Nash Huw M. · CIK 0001780085 · COO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,097

Underlying: Common Stock · 5,700 shares

Expires 2018-12-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option vested as to 1/48th of the total shares on November 22, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date.

SEC source: 0001209191-20-061591 · doc4.xml · nonDerivative · entry 5

Nash Huw M. · CIK 0001780085 · COO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.63 to $52.99 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-20-061591 · doc4.xml · nonDerivative · entry 4

Nash Huw M. · CIK 0001780085 · COO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-20-061591 · doc4.xml · nonDerivative · entry 3

Nash Huw M. · CIK 0001780085 · COO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.78 to $50.41 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-20-061591 · doc4.xml · nonDerivative · entry 2

Nash Huw M. · CIK 0001780085 · COO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,981

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.74 to $49.69 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-20-061591 · doc4.xml · nonDerivative · entry 1

Nash Huw M. · CIK 0001780085 · COO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,700

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-060751 · doc4.xml · nonDerivative · entry 1

Kaye Edward M. MD · CIK 0001522780 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-20-060558 · doc4.xml · nonDerivative · entry 1

Kaye Edward M. MD · CIK 0001522780 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,152

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-20-060543 · doc4.xml · nonDerivative · entry 1

Harrison Seth Loring · CIK 0001404955 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Apple Tree Partners IV, L.P.

Disclosed balance after: 17,161,713

F1 · ownership.nature: Represents shares held by Apple Tree Partners IV, L.P. ("ATP IV"). ATP III GP, Ltd. ("ATP III") is the sole general partner of ATP IV. The reporting person is the sole director of ATP III and may be deemed to have sole voting and dispositive power over the shares held by ATP IV, but disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.

SEC source: 0001209191-20-060542 · doc4.xml · nonDerivative · entry 1

Apple Tree Partners IV, L.P. · CIK 0001593440 · 10% owner

ATP III GP, Ltd. · CIK 0001593453 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,161,713

F1 · ownership.direct: Represents shares held by Apple Tree Partners IV, L.P. ("ATP IV"). ATP III GP, Ltd. ("ATP III") is the sole general partner of ATP IV. Seth Harrison, a director of the issuer, is the sole director of ATP III and may be deemed to have sole voting and dispositive power over the shares held by ATP IV, but disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.

SEC source: 0001209191-20-060549 · doc4.xml · derivative · entry 6

TZIANABOS ARTHUR · CIK 0001586226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,447

Underlying: Common Stock · 20,000 shares

Expires 2028-12-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option vested as to 1/48th of the total shares on October 4, 2018 and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date.

SEC source: 0001209191-20-060549 · doc4.xml · nonDerivative · entry 5

TZIANABOS ARTHUR · CIK 0001586226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.47 to $47.71 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-20-060549 · doc4.xml · nonDerivative · entry 4

TZIANABOS ARTHUR · CIK 0001586226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 210

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.42 to $47.35 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-20-060549 · doc4.xml · nonDerivative · entry 3

TZIANABOS ARTHUR · CIK 0001586226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,504

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.42 to $46.41 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-20-060549 · doc4.xml · nonDerivative · entry 2

TZIANABOS ARTHUR · CIK 0001586226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,700

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.41 to $45.40 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-20-060549 · doc4.xml · nonDerivative · entry 1

TZIANABOS ARTHUR · CIK 0001586226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-057717 · doc4.xml · derivative · entry 5

Nash Huw M. · CIK 0001780085 · COO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,797

Underlying: Common Stock · 13,414 shares

Expires 2028-12-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested as to 1/48th of the total shares on November 22, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date.

SEC source: 0001209191-20-057717 · doc4.xml · derivative · entry 4

Nash Huw M. · CIK 0001780085 · COO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 222,371

Underlying: Common Stock · 36,586 shares

Expires 2028-04-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 1/48th of the total shares on February 28, 2018, and then 1/48th of the total shares vest at the end of each month thereafter, subject to the reporting person's continued service to the issuer through each vesting date.

SEC source: 0001209191-20-057717 · doc4.xml · nonDerivative · entry 3

Nash Huw M. · CIK 0001780085 · COO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-20-057717 · doc4.xml · nonDerivative · entry 2

Nash Huw M. · CIK 0001780085 · COO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-057717 · doc4.xml · nonDerivative · entry 1

Nash Huw M. · CIK 0001780085 · COO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,586

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-056953 · doc4.xml · derivative · entry 13

Tulipano Stephen J · CIK 0001360548 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 209,997

Underlying: Common Stock · 33,268 shares

Expires 2029-03-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: The option vested as to 1/4th of the total shares on March 15, 2020, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date.

SEC source: 0001209191-20-056953 · doc4.xml · nonDerivative · entry 10

Tulipano Stephen J · CIK 0001360548 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 602

F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F8 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.81 to $42.19 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-20-056953 · doc4.xml · nonDerivative · entry 9

Tulipano Stephen J · CIK 0001360548 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,818

F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F7 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.78 to $41.74 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-20-056953 · doc4.xml · nonDerivative · entry 8

Tulipano Stephen J · CIK 0001360548 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,929

F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.76 to $40.73 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-20-056953 · doc4.xml · nonDerivative · entry 7

Tulipano Stephen J · CIK 0001360548 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,870

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-056953 · doc4.xml · derivative · entry 12

Tulipano Stephen J · CIK 0001360548 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 243,265

Underlying: Common Stock · 1,732 shares

Expires 2029-03-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: The option vested as to 1/4th of the total shares on March 15, 2020, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date.